Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  European Journal of Obstetrics, Gynecology, and Reproductive Biology

• Publication date

  2002-06-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0301-2115(02)00010-6PMID 12039463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of an optimal luteal phase support protocol in IVF

  2001cited by this paper
• Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support

  2001cited by this paper
• Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women(3).

  2000cited by this paper
• Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study.

  1999cited by this paper
• Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles.

  1999cited by this paper
• Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles.

  1999cited by this paper
• Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer.

  1999cited by this paper
• Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus.

  1999cited by this paper
• Experience with a novel vaginal progesterone preparation in a donor oocyte program.

  1998cited by this paper
• Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization.

  1998cited by this paper
• Targeted drug delivery in gynaecology: the first uterine pass effect.

  1997cited by this paper
• The First Uterine Pass Effect

  1997cited by this paper
• The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.

  1996cited by this paper
• Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.

  1996cited by this paper
• Transvaginal administration of progesterone : the vaginal paradox and the first uterine pass effect hypothesis

  1995cited by this paper
• Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction

  1994cited by this paper
• A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement.

  1992cited by this paper
• Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.

  1992cited by this paper
• The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme.

  1992cited by this paper
• Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone.

  1990cited by this paper
• Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure.

  1990cited by this paper
• A prospective randomized trial of human chorionic gonadotrophin or dydrogesterone support following in-vitro fertilization and embryo transfer.

  1990cited by this paper
• Hormonal monitoring for in-vitro fertilization and related procedures.

  1988cited by this paper
• The luteal phase after in-vitro fertilization and related procedures.

  1988cited by this paper

• Multicenter cohort study of the effect of Crinone® progesterone vaginal gel alone to prepare the endometrium for frozen–thawed blastocyst transfer in a hormone replacement cycle

  2025cites this paper
• Network meta-analysis of progestogen administration routes for luteal phase support in fresh embryo transfer IVF cycles.

  2025cites this paper
• Clinical efficacy of Crinone on pregnancy outcomes in frozen embryo transfer: A retrospective study in the Chinese population

  2024cites this paper
• Polymers in Vaginal Drug Delivery: Recent Advancements

  2021cites this paper
• Luteal phase support for in vitro fertilization/intracytoplasmic sperm injection fresh cycles: a systematic review and network meta-analysis

  2021cites this paper
• New concepts and difficulties with progesterone supplementation in the luteal phase

  2021cites this paper
• Luteal Phase Defect (LPD): A necessary tool in assisted reproductive techniques

  2021cites this paper
• Progestogens in Infertility Practice

  2021cites this paper
• Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo

  2018cites this paper
• Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles.

  2018cites this paper
• Patient experience in a randomized trial of a weekly progesterone vaginal ring versus a daily progesterone gel for luteal support after in vitro fertilization.

  2018cites this paper
• A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization

  2017cites this paper
• Vaginal use of micronized progesterone for luteal support.A randomized study comparing Utrogestan® and Crinone® 8.

  2017cites this paper
• A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest®) for luteal phase support during IVF treatment

  2017cites this paper
• Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles

  2016cites this paper
• Progesterone vaginal capsule versus vaginal gel for luteal support in normoresponder women undergoing long agonist IVF/ICSI cycles.

  2016cites this paper
• Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia

  2016cites this paper
• Luteal phase support for assisted reproduction cycles.

  2015cites this paper
• Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles

  2015cites this paper
• Level of 17-β Estradiol in follicular fluid for patient undergoes IVF as correlation with pregnancy rate:

  2015cites this paper
• Luteal Phase Support in In Vitro Fertilization

  2015cites this paper
• Luteal Support: What to Use When?

  2015cites this paper
• Level of 17-β Estradiol in follicular fluid for patient undergoes IVF as correlation with pregnancy rate : M . SC

  2015cites this paper
• Serum estradiol and progesterone in the mid-luteal phase predict clinical pregnancy outcome in IVF/ICSI cycles

  2013cites this paper
• Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support

  2013cites this paper
• Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy

  2012cites this paper
• Luteal Phase Support in ART: An Update

  2012cites this paper
• Luteal phase support for in vitro fertilization-embryo transfer--present and future methods to improve successful implantation.

  2012cites this paper
• A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.

  2012cites this paper
• Luteal phase support for assisted reproduction cycles.

  2011cites this paper
• Evidence-Based Use of Progesterone During IVF

  2011cites this paper
• Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.

  2011cites this paper
• Vaginal progesterone gel for luteal phase support in IVF/ICSI cycles: a meta-analysis.

  2010influential citation
• Comparison of Gray Scale Ultrasound and POP-Q System in the Quantification of Pelvic Organ Prolapse

  2010cites this paper
• Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer.

  2010influential citation
• Assessment of the luteal phase in stimulated and substituted cycles.

  2009cites this paper
• A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone.

  2009cites this paper
• Assessment of the luteal phase in stimulated and substituted cycles

  2009cites this paper
• Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: A pilot randomised controlled trial

  2009cites this paper
• Luteal supplementation in in vitro fertilization: more questions than answers.

  2008cites this paper
• WITHDRAWN: Luteal phase support in assisted reproduction cycles.

  2008cites this paper
• Progesterone supplementation during cryopreserved embryo transfer cycles: efficacy and convenience of two vaginal formulations.

  2008cites this paper
• The luteal phase

  2008cites this paper
• Intravaginal oestrogen and progestin administration: advantages and disadvantages.

  2008cites this paper
• The older woman wishing to conceive

  2008cites this paper
• A randomized comparison of side effects and patient convenience between Cyclogest suppositories and Endometrin tablets used for luteal phase support in IVF treatment.

  2007cites this paper
• An update of luteal phase support in stimulated IVF cycles.

  2007influential citation
• Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.

  2007cites this paper
• Comparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles.

  2007cites this paper
• Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles.

  2006cites this paper
• Die vaginale Anwendung von natürlichem Progesteron als Lutealphasenunterstützung nach IVF und Embryotransfer

  2006cites this paper
• Delivery routes of progesterone in assisted reproduction

  2006cites this paper
• Luteal phase support in in-vitro fertilization

  2006cites this paper
• Evidence of improving quality of reporting of randomized controlled trials in subfertility.

  2006cites this paper
• Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.

  2005cites this paper
• Luteal phase support in assisted reproductive technology

  2005cites this paper
• The use of mucoadhesive polymers in vaginal delivery.

  2005cites this paper
• The impact of luteal supplement on pregnancy outcome following stimulated IVF cycles.

  2005cites this paper
• Luteal phase support in assisted reproduction cycles.

  2004cites this paper
• A randomised comparison of side effects and patient inconvenience of two vaginal progesterone formulations used for luteal support in in vitro fertilisation cycles.

  2003cites this paper
• Preparation of cycles for cryopreservation transfers using estradiol patches and Crinone 8% vaginal gel is effective and does not need any monitoring.

  2002cites this paper